Literature DB >> 24619374

Prostate cancer: impact of national guidelines on brachytherapy monotherapy.

Julian Johnson1, Mack Roach1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24619374     DOI： 10.1038/nrurol.2014.50

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  5 in total

1.  Urologists' use of intensity-modulated radiation therapy for prostate cancer.

Authors:  Jean M Mitchell
Journal:  N Engl J Med       Date:  2013-10-24       Impact factor: 91.245

Review 2.  Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.

Authors:  Masaki Kimura; Vladimir Mouraviev; Matvey Tsivian; Janice M Mayes; Takefumi Satoh; Thomas J Polascik
Journal:  BJU Int       Date:  2009-07-02       Impact factor: 5.588

3.  Overview of randomized controlled treatment trials for clinically localized prostate cancer: implications for active surveillance and the United States preventative task force report on screening?

Authors:  Mack Roach; Kimberly Thomas
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

4.  Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.

Authors:  Steven J Frank; Peter D Grimm; John E Sylvester; Gregory S Merrick; Brian J Davis; Anthony Zietman; Brian J Moran; David C Beyer; Mack Roach; Daniel H Clarke; Richard G Stock; W Robert Lee; Jeff M Michalski; Kent E Wallner; Mark Hurwitz; Louis Potters; Deborah A Kuban; Bradley R Prestidge; Robyn Vera; Shannon Hathaway; John C Blasko
Journal:  Brachytherapy       Date:  2007 Jan-Mar       Impact factor: 2.362

5.  Impact of national guidelines on brachytherapy monotherapy practice patterns for prostate cancer.

Authors:  Yolanda D Tseng; Alan T Paciorek; Neil E Martin; Anthony V D'Amico; Matthew R Cooperberg; Paul L Nguyen
Journal:  Cancer       Date:  2013-12-02       Impact factor: 6.860
  5 in total
  1 in total

Review 1.  Nanoways to overcome docetaxel resistance in prostate cancer.

Authors:  Aditya Ganju; Murali M Yallapu; Sheema Khan; Stephen W Behrman; Subhash C Chauhan; Meena Jaggi
Journal:  Drug Resist Updat       Date:  2014-04-05       Impact factor: 18.500
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.